123 related articles for article (PubMed ID: 9794566)
21. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
22. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of malnutrition and inflammation in undialyzed patients with chronic renal failure in developing countries: a single center experience from eastern India.
Prakash J; Raja R; Mishra RN; Vohra R; Sharma N; Wani IA; Parekh A
Ren Fail; 2007; 29(7):811-6. PubMed ID: 17994448
[TBL] [Abstract][Full Text] [Related]
24. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
[TBL] [Abstract][Full Text] [Related]
25. Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress.
Brzeszczynska J; Luciak M; Gwozdzinski K
Free Radic Res; 2008 Jan; 42(1):40-8. PubMed ID: 18324522
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
27. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
[TBL] [Abstract][Full Text] [Related]
28. Nutritional assessment of children on haemodialysis: value of IGF-I, TNF-alpha and IL-1beta.
Beşbaş N; Ozdemir S; Saatçi U; Coşkun T; Ozen S; Topaloğlu R; Bakkaloğlu A; El Nahas AM
Nephrol Dial Transplant; 1998 Jun; 13(6):1484-8. PubMed ID: 9641179
[TBL] [Abstract][Full Text] [Related]
29. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
30. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?
Stenvinkel P; Andersson P; Wang T; Lindholm B; Bergström J; Palmblad J; Heimbürger O; Cederholm T
J Intern Med; 1999 Nov; 246(5):503-7. PubMed ID: 10583720
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in patients with chronic renal failure: effects of hemodialysis.
Durak I; Kaçmaz M; Elgün S; Oztürk HS
Med Princ Pract; 2004; 13(2):84-7. PubMed ID: 14755140
[TBL] [Abstract][Full Text] [Related]
32. [Subjective general assessment of nutritional status in patients with chronic renal failure and regular hemodialysis].
Jerin L; Ladavac R; Kuzmanović G; Dodić D; Griparić D
Acta Med Croatica; 2003; 57(1):23-8. PubMed ID: 12876858
[TBL] [Abstract][Full Text] [Related]
33. [Serum leptin levels in children with chronic renal failure on continuous ambulatory peritoneal dialysis and on hemodialysis treatment].
Szprynger K; Szczepańska M; Kos-Kudła B; Ostrowska Z; Ziora K; Oświecimska J; Schneiberg B
Wiad Lek; 2005; 58 Suppl 1():66-70. PubMed ID: 16060088
[TBL] [Abstract][Full Text] [Related]
34. Plasmalogen levels in full-term neonates.
Labadaridis I; Moraitou M; Theodoraki M; Triantafyllidis G; Sarafidou J; Michelakakis H
Acta Paediatr; 2009 Apr; 98(4):640-2. PubMed ID: 19290965
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
36. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
Pawlak K; Pawlak D; Myśliwiec M
Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
[TBL] [Abstract][Full Text] [Related]
37. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
38. Erythrocyte membrane changes associated with nutrition and aging--the role of plasmalogens.
Brosche T; Summa JD; Platt D
Arch Gerontol Geriatr; 1989; 9(3):291-6. PubMed ID: 2640088
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin in patients with chronic renal failure undergoing dialysis.
Hou FF; Zhang X; Wang AL; Wu JG
Nephron; 1990; 55(1):45-8. PubMed ID: 2352577
[TBL] [Abstract][Full Text] [Related]
40. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
